Delanzomib (CEP-18770)

Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.
Supplier Selleck Chemicals
Product # S1157
Sku # S1157-50mg
Pricing 50mg, $997.00
Feedback